Abbott Diagnostics named Medtech Company of the Year

The Irish Medical Devices Association (IMDA), the Ibec group that represents the medical technology sector, announced Abbott Diagnostics Longford as the Medtech Company of the Year at the Irish Medical Technology Industry Awards, jointly hosted with Enterprise Ireland and IDA Ireland, in the Clontarf Castle Hotel, last night.

As part of Abbott, a diversified global healthcare company, Abbott Diagnostics Longford manufactures diagnostic tests, also known as reagents, for distribution across the globe to hospitals and laboratories. The product portfolio includes reagents for the detection of thyroid, fertility / pregnancy, cardiology, renal and metabolic markers. Through the “Becoming World Class” programme, Abbott Diagnostics Longford has developed an organization that is focused on the needs of its customers and a site wide ‘Continuous Improvement’ culture which has enabled operational excellence. These efforts have improved product quality and delivery while yielding exceptional volume expansion.

Director of the IMDA Sinead Keogh said: “It’s been nearly a decade since we launched the awards and in that time the sector has prospered with the number of companies in Ireland rising to over 400 this year. Since the beginning of 2014, over 2,000 jobs have been announced in the sector. It’s vital that strategic sectors which drive regional growth are supported: tonight’s winners Abbott Diagnostic Longford, AventaMed in Cork and the University of Limerick highlight regional successes.”


· Medtech Company of the Year Award: Abbott Diagnostics Longford; Silver Award Winners Stryker
· Emerging Company Award: AventaMed
· Academic Contribution to Medtech Award: University of Limerick, Department of Mechanical, Aeronautical and Biomedical Engineering
· Outstanding Contribution to Medtech: Barry O’Leary,  Former CEO of IDA Ireland

IDA Ireland Head of Medical Technologies Michael Lohan said: “The medtech sector has already announced more than €309 million of investments this year and remains optimistic about Ireland’s future. The awards are a fantastic opportunity for both multinational and Irish indigenous companies to display their latest products and services and we are delighted to be able to announce such worthy and accomplished winners.”

Enterprise Ireland Senior Development Advisor Life Sciences Department John Shiel said: “This is our third year to have a collaborative Academic Contribution to the Medtech Awards. The University of Limerick collaboration with Stryker, supported by the Irish Research Council, is the world’s first FDA approved injectable for bone repair material (hydroxyapatite). It has been developed and manufactured in Ireland and used in neurosurgical procedures since November. This is a great example of the importance of academia working with industry to deliver better results for patients.”

Abbott Diagnostics Longford Site Director Ciaran Corcoran said: “We are delighted to receive this award on behalf of all our employees in Abbott Diagnostics Longford. Through their creativity and relentless focus on our vision of ‘World Class Performance in Everything We Do,’ they have delivered truly outstanding and sustainable results. We would like to thank the Irish Medical Devices Association (IMDA), Enterprise Ireland and IDA Ireland for this award.  We are incredibly humbled to be honoured in such a way by our peers in the Irish medtech sector.”

AventaMed CEO Olive O’Driscoll said: “The AventaMed team are proud to provide a new treatment option and improved quality of care for patients undergoing ear tube surgery. We are thrilled to receive the Emerging Medtech Company of the Year Award, which is the most prestigious accolade for Irish medical device companies. Winning the award is a reflection of the growing trend in paediatric medicine for less invasive surgery and innovations such as ours, which minimises the use of anaesthetics and reduces healthcare costs.”

Eamonn De Barra said: “We are absolutely delighted to win this award. It emphasises the success and impact that is possible via collaboration between a leading medical device multinational such as Stryker and responsive and focussed research institutes such as the HRI and Bernal Institutes at UL. We hope this success marks a new chapter in our continued and expanding collaboration between Stryker and the University of Limerick, to the continued benefit of patients and surgeons. We would like to gratefully acknowledge the support of The Irish Research Council under their Enterprise Partnership Scheme.”

The shortlisted organisations were:

Medtech Company of the Year: Boston Scientific and The Tech Group
Emerging Medtech Company Award: Incereb and SurgaColl
Academic Contribution to Medtech: Biomedical Diagnostics Institute, Dublin City University and UCC BioDesign

For more please click: http://www.ibec.ie/IBEC/Press/PressPublicationsdoclib3.nsf/vPages/Newsroom~abbott-diagnostics-named-medtech-company-of-the-year-11-12-2015?OpenDocument#.VmsAd5Wvn4g

We use cookies to give you the best online experience. By agreeing you consent the use of cookies in accordance with our Privacy Statement and cookie settings in your Privacy Settings below.

Privacy Settings saved!
Privacy Settings

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie

Decline all Services
Accept all Services